Clincosm LogoSign in Get a demo

Growth Pattern and Characteristics of Cardiac Pediatric Patients

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05577130
Collaborator
(none)
50
Enrollment
13.9
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

Congenital heart disease (CHD) is the most common congenital anomaly in the body, affecting about 8 per 1000children. cardiovascular disorders are the most debilitating and one of causes of organic growth disorders in children.Malnutrition is a constant phenomenon among children with CHD. The degree and type of malnutrition may be related to characteristics of the CHD, including presence of cyanosis, congestive heart failure (CHF), or pulmonary hypertension (PHTN).

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    At birth, the weight and length of children with CHD are close to normal and APGAR scores are generally high. Cyanotic patients are affected in growth, depending on the severity of tissue hypoxemia and on the degree of physiological variation. Mostly acute malnutrition occurs in a cyanotic heart disease but chronic malnutrition occurs in cyanotic lesions. The severity of malnutrition variety from mild under nutrition to failure to thrive. impairing growth and increasing post-operative morbidity and mortality. Early rapid growth retardation detection in early age and improved nutritional status have the potential to reduce cardiac impact on growth and feeding. Insure appropriate nutrition in those patients by the two main methods (enteral and parenteral) help in better outcome

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    50 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Other
    Official Title:
    Growth Pattern and Characteristics of Cardiac Pediatric Patients Attending Assiut University Children Hospital and Sidi Galal Health Insurance Clinic
    Anticipated Study Start Date :
    Nov 1, 2022
    Anticipated Primary Completion Date :
    Oct 30, 2023
    Anticipated Study Completion Date :
    Dec 30, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Study the pattern of growth in infant and children with heart diseases. [through study completion, an average of 1 year.]

      By measurement of : Weight in (Kg)and height in (m) will be combined to report BMI in kg/m^2). Measure mid arm circumference in (cm) & head circumference in(cm)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 4 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Age: 0-4 years old

    • Male and female,

    • diagnosed as cardiac diseased children

    Exclusion Criteria:

    • children more than 4 years old

    • not genetic disorder as down syndrome This is a descriptive study.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Assiut University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Safaa Ahmed Mohamed, Resident doctor in family medicine, Assiut University
    ClinicalTrials.gov Identifier:
    NCT05577130
    Other Study ID Numbers:
    • GPACOCPAAUCHASGHIC
    First Posted:
    Oct 13, 2022
    Last Update Posted:
    Oct 13, 2022
    Last Verified:
    Oct 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Growth Disorders

    Study Results

    No Results Posted as of Oct 13, 2022